Cytokine-mediated neurologic disease in COVID-19
COVID-19 中细胞因子介导的神经系统疾病
基本信息
- 批准号:10704594
- 负责人:
- 金额:$ 7.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAcuteAddressAnosmiaAnxietyAstrocytesAttentionAttentional deficitAutopsyBehavior ControlBehavioralBlood - brain barrier anatomyBlood brain barrier dysfunctionBody Weight decreasedBrainBrain regionC57BL/6 MouseCOVID-19COVID-19 pathogenesisCOVID-19 patientCellsCentral Nervous SystemCognitionCognitive deficitsCommunicable DiseasesCoronavirusCoughingCre-LoxPDataDefectEndothelial CellsFatigueFeverFollow-Up StudiesGenerationsHamstersHeadacheHemorrhageHippocampusHumanHypoxiaIL1R1 geneImmuneImmune responseImmune signalingImmunohistochemistryImmunologicsImpaired cognitionIn VitroIndividualInfarctionInfectionInflammationInflammatoryInflammatory ResponseInjuryInterleukin-1Interleukin-1 betaIschemiaLearningLoxP-flanked alleleLungMediatingMemoryMemory impairmentMicrogliaModelingMovement DisordersMusNervous System TraumaNeuroimmunomodulationNeurologic DysfunctionsNeurologic SymptomsNeuronsNodulePatientsPeripheralPharmacological TreatmentProductionPsychosesRecoveryReportingResolutionRespiratory DiseaseRespiratory SystemRoleSARS-CoV-2 B.1.351SARS-CoV-2 infectionSamplingSignal InductionSignal PathwaySignal TransductionSourceSpecimenSurveysSymptomsSynapsesSyndromeTestingTight JunctionsTissuesVariantViral Load resultVirus Diseasesabstractingattentional controlaxon injurybehavior testbetacoronavirusblood-brain barrier disruptionblood-brain barrier permeabilizationbrain endothelial cellcytokineexcitatory neuronexecutive functionexperimental studyglial activationimmune activationinducible Creinsightmouse modelnerve stem cellnervous system disorderneural correlateneurogenesisneuroimagingneuroinflammationneurotoxicnovelnovel coronaviruspandemic diseasepost SARS-CoV-2 infectionreceptorrecruitresponsesevere COVID-19spatial memorystem cell differentiationsynaptogenesis
项目摘要
PROJECT SUMMARY
The newly emerged coronavirus, SARS-CoV-2, has caused a historic pandemic of respiratory disease (COVID-
19). One surprising finding, is that both mild and severe COVID-19 is associated with persistent neurological
symptoms, even after resolution of infection. Patients present with a variety of symptoms, from deficits in
attention, planning, and other executive functions, to memory impairment, or new psychoses. Post-mortem
analyses of brains from individuals with COVID-19 did not find evidence of infectious SARS-CoV-2 in the
parenchyma. However, COVID-19 infection is associated with an array of neurological injury, including infarcts,
ischemia, hemorrhages, and hypoxia. Immunohistochemistry on post-mortem specimens demonstrated that
SARS-CoV-2 infection is associated with blood-brain barrier (BBB) disruption, elevated levels of the pro-
inflammatory cytokine, IL-1β, and microglial activation and nodules, and neuronophagia. In other neurovirulent
viral infections, IL-1β promotes inflammation in the central nervous system via disruption of the blood-brain
barrier and recruitment of immune cells that activate microglia, which eliminate synapses in the hippocampus, a
brain region critical for learning and memory. During recovery, IL-1β inhibits neurogenesis, which limits synapse
recovery, and induces spatial memory defects. We hypothesize that IL-1β production in the brain during SARS-
CoV-2 infection potentiates neurological dysfunction by disrupting the BBB and promoting cognitive and memory
deficits. To investigate this, we will use a C57Bl/6 mouse model of COVID-19, in which mice are intranasally
infected with B.1.351 (Beta variant), which naturally infects mice. In Aim 1, we will investigate the role of IL-1R1
signaling on BBB disruption using a brain microvascular endothelial cell (BMEC) specific inducible Cre crossed
to IL-1R floxed mice. We will also determine if IL-1R1 signaling promotes activation of BMECs and the induction
of inflammation. In Aim 2, we will explore if IL-1R1 signaling impacts cognition and memory via inhibition of
neurogenesis within ongoing synapse elimination. First, we will determine the impact of IL-1R1 on neurogenesis
during infection with B.1.351 using neural stem cell (NSC) specific, inducible Cre mice crossed to IL-1R floxed
mice. Next, we test the role of IL-1R1 signaling on recovery of the hippocampal trisynaptic cirucuit via NSC-
specific or microglial-specific Cre-IL-1R1 floxed mice. Last, using the same mice as the previous experiment, we
will perform behavioral tests on mice recovered from B.1.351 to examine the functional impact of IL-1R1
signaling. Together, in this proposal we will explore the immunological mechanisms that underlie neurological
dysfunction during COVID-19.
项目概要
新出现的冠状病毒 SARS-CoV-2 引起了历史性的呼吸道疾病大流行 (COVID-19)。
19) 一项令人惊讶的发现是,轻度和重度 COVID-19 都与持续性神经系统疾病有关。
症状,即使在感染消退后,患者也会因缺乏功能而出现各种症状。
注意力、计划和其他执行功能,记忆障碍或新的精神病。
对 COVID-19 患者大脑的分析没有发现感染性 SARS-CoV-2 的证据
然而,COVID-19 感染与一系列神经损伤有关,包括梗死、
尸检标本的缺血、出血和缺氧。
SARS-CoV-2 感染与血脑屏障 (BBB) 破坏、亲细胞水平升高有关。
炎症细胞因子、IL-1β、小胶质细胞激活和结节,以及其他神经毒力中的神经吞噬。
病毒感染时,IL-1β 通过破坏血脑促进中枢神经系统炎症
屏障和招募激活小胶质细胞的免疫细胞,消除海马体中的突触,
对学习和记忆至关重要的大脑区域 在恢复过程中,IL-1β 会抑制神经发生,从而限制突触。
我们捕获了 SARS 期间大脑中 IL-1β 的产生。
CoV-2 感染通过破坏血脑屏障并促进认知和记忆来加剧神经功能障碍
为了研究这一缺陷,我们将使用 COVID-19 的 C57Bl/6 小鼠模型,其中小鼠经鼻注射。
感染 B.1.351(Beta 变体),该病毒自然感染小鼠。在目标 1 中,我们将研究 IL-1R1 的作用。
使用脑微血管内皮细胞 (BMEC) 特异性诱导型 Cre 杂交对 BBB 破坏发出信号
我们还将确定 IL-1R1 信号传导是否促进 BMEC 的激活和诱导。
在目标 2 中,我们将探讨 IL-1R1 信号传导是否通过抑制炎症影响认知和记忆。
持续突触消除过程中的神经发生 首先,我们将确定 IL-1R1 对神经发生的影响。
在感染 B.1.351 期间,使用神经干细胞 (NSC) 特异性、可诱导的 Cre 小鼠与 IL-1R floxed 杂交
接下来,我们通过 NSC- 测试 IL-1R1 信号传导对海马三突触回路恢复的作用。
最后,我们使用与之前实验相同的小鼠。
将对从 B.1.351 恢复的小鼠进行行为测试,以检查 IL-1R1 的功能影响
在本提案中,我们将共同探讨神经学基础的免疫机制。
COVID-19 期间功能障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Abigail Rose Vanderheiden其他文献
Abigail Rose Vanderheiden的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Abigail Rose Vanderheiden', 18)}}的其他基金
Cytokine-mediated neurologic disease in COVID-19
COVID-19 中细胞因子介导的神经系统疾病
- 批准号:
10509125 - 财政年份:2022
- 资助金额:
$ 7.22万 - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Elucidating the immunology of autoantibody formation and function in COVID-19
阐明 COVID-19 中自身抗体形成和功能的免疫学
- 批准号:
10639707 - 财政年份:2023
- 资助金额:
$ 7.22万 - 项目类别:
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
- 批准号:
10797938 - 财政年份:2023
- 资助金额:
$ 7.22万 - 项目类别:
Natural model for evaluating within- and cross-species virus transmission
评估物种内和跨物种病毒传播的自然模型
- 批准号:
10735974 - 财政年份:2023
- 资助金额:
$ 7.22万 - 项目类别:
Optimizing the Generation of Monoclonal Antibodies for Prevention and Treatment of HSV Disease
优化用于预防和治疗 HSV 疾病的单克隆抗体的生成
- 批准号:
10717320 - 财政年份:2023
- 资助金额:
$ 7.22万 - 项目类别:
Adjuvant effect of physical exercise on immune response to COVID-19 vaccination and interactions with stress
体育锻炼对 COVID-19 疫苗接种免疫反应的辅助作用以及与压力的相互作用
- 批准号:
10593597 - 财政年份:2023
- 资助金额:
$ 7.22万 - 项目类别: